antiprimod has been researched along with Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akdeniz, BS; Akkoc, T; Arisan, ED; Coker-Gurkan, A; Ergen, B; Obakan-Yerlikaya, P; Ozakaltun, B | 1 |
| Arisan, ED; Can, E; Coker-Gurkan, A; Obakan-Yerlikaya, P; Sahin, S | 1 |
2 other study(ies) available for antiprimod and Breast Cancer
| Article | Year |
|---|---|
Proinflammatory cytokine profile is critical in autocrine GH-triggered curcumin resistance engulf by atiprimod cotreatment in MCF-7 and MDA-MB-231 breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Proliferation; Cell Survival; Curcumin; Cytokines; Female; Human Growth Hormone; Humans; MCF-7 Cells; Spiro Compounds | 2020 |
Atiprimod triggered apoptotic cell death via acting on PERK/eIF2α/ATF4/CHOP and STAT3/NF-ΚB axis in MDA-MB-231 and MDA-MB-468 breast cancer cells.
Topics: Activating Transcription Factor 4; Apoptosis; Autophagy; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; eIF-2 Kinase; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factor-2; Female; Humans; NF-kappa B; Reactive Oxygen Species; Spiro Compounds; STAT Transcription Factors; STAT3 Transcription Factor; Transcription Factor CHOP | 2021 |